Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2022-03-08 AGM Information
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Telcon RF Pharmaceutical. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits). This document serves as the official solicitation and notification to shareholders regarding an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2022-03-08 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal notification filed by Telcon RF Pharmaceutical regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the regulatory and audit-related reasons for choosing this date and mentions the implementation of electronic voting to mitigate shareholder participation issues. This is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results of the meeting.
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with Form 14A-like disclosures) used to solicit votes from shareholders for an upcoming Annual General Meeting (AGM). It contains details about the meeting, the purpose of the solicitation, and proxy voting procedures. While it includes financial statements, these are provided as reference materials for the shareholders to review before the meeting, not as the primary Annual Report itself. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2022-03-08 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the adjustment of conversion prices for convertible bonds (CBs). This type of disclosure, which involves changes to capital structure and financial instruments, is classified under 'Capital/Financing Update' (CAP) as it directly relates to the company's financing activities and debt-to-equity conversion terms.
2022-02-28 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the adjustment of conversion prices for convertible bonds (CBs) due to a decline in stock price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it does not fit into specific categories like M&A, dividends, or director dealings, and is a direct regulatory disclosure of a financial event rather than a report publication announcement, it falls under the 'Regulatory Filings' category.
2022-02-03 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) detailing the exercise of conversion rights (전환청구권행사) for convertible bonds into common shares. This type of filing directly impacts the company's capital structure by increasing the number of outstanding shares. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2021-12-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.